Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
ESMO 2026: Latest video and news updates here
ESMO 2026: Latest video and news updates here

Radiogenomics consortium

Prof Catherine West - University of Manchester, United Kingdom
Radiogenomics consortium ( Prof Catherine West - University of Manchester, United Kingdom )
6 Oct 2010

EGFR induced radiotherapy resistance in tumour cells

Prof Hans Peter Rodemann - University of Tübingen, Germany
EGFR induced radiotherapy resistance in tumour cells ( Prof Hans Peter Rodemann - University of Tübingen, Germany )
6 Oct 2010

Developments in the treatment of glioblastoma brain tumours

Prof René-Olivier Mirimanoff - Universitaire Vaudois, Lausanne, Switzerland
Developments in the treatment of glioblastoma brain tumours ( Prof René-Olivier Mirimanoff - Universitaire Vaudois, Lausanne, Switzerland )
6 Oct 2010

ESTRO 2010

Prof. Vincent Gregoire - Université Catholique de Louvain, Brussels, Belgium
ESTRO 2010 ( Prof. Vincent Gregoire - Université Catholique de Louvain, Brussels, Belgium )
6 Oct 2010

Advances in the treatment of rectal cancer

Prof Jean-Pierre Gerard - Centre Antoine-Lacassagne, Nice, France
Advances in the treatment of rectal cancer ( Prof Jean-Pierre Gerard - Centre Antoine-Lacassagne, Nice, France )
6 Oct 2010

The benefits of RapidArc and other new radiosurgery technologies

Prof Luca Cozzi - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
The benefits of RapidArc and other new radiosurgery technologies ( Prof Luca Cozzi - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )
6 Oct 2010

Head and neck cancer

Dr Lisa Licitra, Istituto Nazionale dei Tumori, Milan, Italy
Head and neck cancer ( Dr Lisa Licitra, Istituto Nazionale dei Tumori, Milan, Italy )
29 Sep 2010

PARP inhibitors

Professor Thomas Helleday, Oxford University, UK and Prof Anthony Chalmers, University of Glasgow, UK.
PARP inhibitors ( Professor Thomas Helleday, Oxford University, UK and Prof Anthony Chalmers, University of Glasgow, UK. )
29 Sep 2010

The use of hormone therapy to treat advanced prostate cancer

Dr Heather Payne, University College London, UK
The use of hormone therapy to treat advanced prostate cancer ( Dr Heather Payne, University College London, UK )
29 Sep 2010

The importance of a multi-disciplinary approach to the development of cancer treatments

Prof Michael Baumann, University of Technology, Dresden, Germany
The importance of a multi-disciplinary approach to the development of cancer treatments ( Prof Michael Baumann, University of Technology, Dresden, Germany )
29 Sep 2010

Cross border healthcare: a necessity for cancer patients

John Dalli - European Commissioner for Health and Consumer Policy
Cross border healthcare: a necessity for cancer patients ( John Dalli - European Commissioner for Health and Consumer Policy )
24 Sep 2010

Defining molecular profiles on circulating tumour cells

Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Italy
Defining molecular profiles on circulating tumour cells ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital, Italy )
20 Sep 2010

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation